Literature DB >> 26070762

"Legal Highs"--An Emerging Epidemic of Novel Psychoactive Substances.

Jolanta B Zawilska1.   

Abstract

During the last decade, there has been an increase in the availability and use of novel psychoactive substances (NPS), also known as "legal highs," across the world. They include a wide range of products, from natural plant-originated substances to synthetic compounds, that can be purchased both online and from high street retailers. "Legal highs" mimic psychoactive effects of illicit drugs of abuse. However, they are claimed to consist of compounds that are legal to sell, possess, and use, often labeled as "not for human consumption" to circumvent drug abuse legislation. Based on the spectrum of their actions on cognitive processes, mood, and behavior, "legal highs" can be classified into four basis categories: amphetamine- and ecstasy-like stimulants, synthetic cannabinoids (SCs), hallucinogenic/dissociative, and opioid-like compounds. NPS may, however, exhibit a combination of these actions due to their designed chemical structure. Although the prevalence and pattern of NPS use differ between various countries, the most popular groups are SCs and psychostimulants, described in this chapter. Currently, there is limited information available on the potential acute toxicity (harms) associated with the use of these substances. However, the number of intoxicated people presenting with emergencies is constantly increasing, providing evidence that negative health and social consequences may indeed seriously affect recreational and chronic users.
© 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  2-Aminoindanes; 2C drugs; Cathinones; Piperazines; Psychoactive compounds; Synthetic cannabinoids; “Legal highs”

Mesh:

Substances:

Year:  2015        PMID: 26070762     DOI: 10.1016/bs.irn.2015.02.009

Source DB:  PubMed          Journal:  Int Rev Neurobiol        ISSN: 0074-7742            Impact factor:   3.230


  12 in total

Review 1.  Poisonous or non-poisonous plants? DNA-based tools and applications for accurate identification.

Authors:  Valerio Mezzasalma; Ioannis Ganopoulos; Andrea Galimberti; Laura Cornara; Emanuele Ferri; Massimo Labra
Journal:  Int J Legal Med       Date:  2016-10-30       Impact factor: 2.686

2.  Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances.

Authors:  Elena Deligianni; Omari J Daniel; John M Corkery; Fabrizio Schifano; Lisa A Lione
Journal:  Br J Clin Pharmacol       Date:  2020-01-09       Impact factor: 4.335

Review 3.  Contribution of Illicit Drug Use to Pharmaceutical Load in the Environment: A Focus on Sub-Saharan Africa.

Authors:  Asha S Ripanda; Mwemezi J Rwiza; Elias Charles Nyanza; Revocatus L Machunda; Said Hamadi Vuai
Journal:  J Environ Public Health       Date:  2022-06-08

4.  Cytotoxic Activity of Pyrovalerone Derivatives, an Emerging Group of Psychostimulant Designer Cathinones.

Authors:  Jakub Wojcieszak; Dariusz Andrzejczak; Agata Woldan-Tambor; Jolanta B Zawilska
Journal:  Neurotox Res       Date:  2016-06-13       Impact factor: 3.911

Review 5.  Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants.

Authors:  Cristina Miliano; Giovanni Serpelloni; Claudia Rimondo; Maddalena Mereu; Matteo Marti; Maria Antonietta De Luca
Journal:  Front Neurosci       Date:  2016-04-19       Impact factor: 4.677

Review 6.  Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health.

Authors:  Aviv M Weinstein; Paola Rosca; Liana Fattore; Edythe D London
Journal:  Front Psychiatry       Date:  2017-08-23       Impact factor: 4.157

7.  A Recent Human Immunodeficiency Virus Outbreak Among People Who Inject Drugs in Munich, Germany, Is Associated With Consumption of Synthetic Cathinones.

Authors:  Kirsten Hanke; Stefan Fiedler; Christina Grumann; Oliver Ratmann; Andrea Hauser; Patrycja Klink; Karolin Meixenberger; Britta Altmann; Ruth Zimmermann; Ulrich Marcus; Viviane Bremer; Volker Auwärter; Norbert Bannert
Journal:  Open Forum Infect Dis       Date:  2020-05-27       Impact factor: 3.835

8.  "Hot" and "Cold" Cognition in Users of Club Drugs/Novel Psychoactive Substances.

Authors:  George Savulich; Owen Bowden-Jones; Robert Stephenson; Annette B Brühl; Karen D Ersche; Trevor W Robbins; Barbara J Sahakian
Journal:  Front Psychiatry       Date:  2021-03-24       Impact factor: 4.157

Review 9.  Why Do Marijuana and Synthetic Cannabimimetics Induce Acute Myocardial Infarction in Healthy Young People?

Authors:  Jolanta Weresa; Anna Pędzińska-Betiuk; Krzysztof Mińczuk; Barbara Malinowska; Eberhard Schlicker
Journal:  Cells       Date:  2022-03-28       Impact factor: 6.600

10.  A Curious Case of Inhalation Fever Caused by Synthetic Cannabinoid.

Authors:  Thiru Chinnadurai; Srijan Shrestha; Raji Ayinla
Journal:  Am J Case Rep       Date:  2016-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.